Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02258594 · ClinicalTrials.gov registry record · NA
Promoting Respect and Ongoing Safety Through Patient-centeredness, Engagement, Communication and Technology
A NA study, sponsored by Brigham and Women's Hospital.
- Completed
- Registry status
- NA
- Development phase
- 4,368
- Enrollment target
NCT02258594: Completed NA study, sponsored by Brigham and Women's Hospital.
NCT02258594 is a NA study that has completed, run by Brigham and Women's Hospital. The registered enrollment target is 4,368 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (211% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02258594, a NA study, has completed, sponsored by Brigham and Women's Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 4,368 participants
- Enrollment target
Study Summary
The purpose of this project is to refine, implement, and evaluate a multi-component intervention that achieves sustainable and meaningful impact on healthcare quality, safety, and costs while ensuring dignity and respect for adult oncology and intensive care patients and their care partners. The PROSPECT (Promoting Respect and Ongoing Safety through Patient-centeredness, Engagement, Communication, and Technology) framework will achieve this by enhancing the patient-provider relationship and introducing patient-centered approaches to multi-disciplinary communication and patient education. The PROSPECT framework is based upon a validated structured, team-work training model and novel web-based technology. The overarching goals of this project are to achieve the following: 1. Optimize the overall experience of patients (including their family/care partners) by promoting dignity/respect, encouraging engagement, improving care plan concordance, and enhancing satisfaction. 2. Minimize preventable harms in two environments: intensive care and acute care oncology units. 3. Reduce unnecessary healthcare resource utilization and associated costs.
Primary Outcome
Preventable adverse events in the acute care setting include medication errors, patient falls, veno-thromboembolism, hospital acquired infection, central line related bloodstream infection, ventilator associated pneumonia, catheter associated urinary tract infection, newly acquired physical harm/injury. We will measure the rate of adverse events acquired from the time of admission to study units through hospital discharge. Using an adaptation of the Institute for Healthcare Improvement (IHI) Glo
Interventions
- OTHER Web-Based Patient Centered Toolkit (PCTK)
- BEHAVIORAL The Patient-SatisfActive® Model
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4,368 participants |
| Start Date | 2013-03 |
| Est. Completion | 2015-06 |
| Phase | NA |
What the finished NCT02258594 record still lists
NCT02258594 is an interventional study that assigns participants to a tested intervention. Its 4,368 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (211% higher).
The record links to 0 conditions, and to 2 interventions - of which Web-Based Patient Centered Toolkit (PCTK) is the first listed.
NCT02258594 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02258594 about?
NCT02258594 is a clinical study titled "Promoting Respect and Ongoing Safety Through Patient-centeredness, Engagement, Communication and Technology". The purpose of this project is to refine, implement, and evaluate a multi-component intervention that achieves sustainable and meaningful impact on healthcare quality, safety, and costs while ensuring dignity and respect for adult oncology and intensive care patients and their care partners. The PRO...
What is the current status of trial NCT02258594?
This trial is currently completed. It is a NA study. The enrollment target is 4,368 participants. The study started on 2013-03. Estimated completion is 2015-06.
What interventions are being tested in trial NCT02258594?
The interventions under investigation include: Web-Based Patient Centered Toolkit (PCTK) (OTHER), The Patient-SatisfActive® Model (BEHAVIORAL).
Who is sponsoring clinical trial NCT02258594?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02258594's enrollment target sits among peer trials
4,368 30th of 2000 higher than 1,971 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07044297 · 4,390 participants · Phase 3
A Clinical Study of MK-8527 to Prevent Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8527-011)
- NCT05910567 · 4,346 participants · NA
A Research Study of Abdominal Ultrasound (FAST) in Children With Blunt Torso Trauma
- NCT02660645 · 4,400 participants
Blue Light Cystoscopy With Cysview® Registry
- NCT05774951 · 4,300 participants · Phase 3
A Study of Camizestrant in ER+/HER2- Early Breast Cancer After at Least 2 Years of Standard Adjuvant Endocrine Therapy
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia